Omnicell Stock - Thursday chart update with 200-day line in view
18.06.2026 - 22:51:28 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:49 UTC. Details in the imprint.
Omnicell (US6821321088) trades through a technically quiet Thursday, with no fresh company news or filings hitting the tape. Instead, investors are watching how the shares behave around key chart levels on the Nasdaq.
Background and price data on Omnicell stock
Key figures, historical news and additional Omnicell stock analysis are collected on the ad-hoc-news topic page and the company's Investor Relations site.
What today's chart shows
There was no new Omnicell-specific headline from Investor Relations, Reuters, Bloomberg, the Wall Street Journal or filings on Thursday, leaving the focus on the price trend itself.
On a daily chart, Omnicell shares continue to trade in a medium-term range that has defined the stock for several months, with neither buyers nor sellers yet forcing a clear breakout.
Focus on the 200-day moving average
For technically minded investors, the 200-day moving average is a key reference line that often acts as support or resistance in established trends.
Based on recent Nasdaq data, Omnicell shares are currently trading in the vicinity of that long-term average, underlining how indecisive the market remains about the company after earlier volatility this year.
How the stock has traded recently
Over recent weeks, Omnicell shares have seen alternating positive and negative sessions without a sustained directional push, mirroring the more balanced risk appetite in parts of the wider healthcare technology space.
Day-to-day percentage changes have largely stayed within a mid-single-digit band, suggesting that, for now, trading is driven more by short-term positioning than by fresh fundamental information on the company.
The product behind the stock
Omnicell generates most of its revenue with automated medication management and adherence solutions for hospitals and pharmacies, including dispensing cabinets, pharmacy automation systems and software platforms that help reduce errors and improve drug inventory control.
Where the stock trades today
Omnicell shares (US6821321088) trade on the Nasdaq at $XX.XX as of 06/18/2026, 20:30 UTC.
Key facts on Omnicell stock
- Company: Omnicell Inc.
- ISIN: US6821321088
- WKN: 926336
- Ticker: OMCL
- Venue: Nasdaq
- Price (as of 06/18/2026, 20:30 UTC): $XX.XX
- Market cap: $X,XXX million (as of 06/18/2026)
- Sector / Industry: Health Care Technology / Medical Devices
- Index membership: not a member of major headline indices such as the S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
